Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UNIVERSAL URGENT CARE AND OCCUPATIONAL MEDICINE, INC.

NPI: 1346646775 · BAKERSFIELD, CA 93312 · Family Medicine Physician · NPI assigned 11/12/2014

$6.25M
Total Medicaid Paid
113,876
Total Claims
103,677
Beneficiaries
38
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPARMAR, ASHOK (PRESIDENT)
NPI Enumeration Date11/12/2014

Related Entities

Other providers sharing the same authorized official: PARMAR, ASHOK

ProviderCityStateTotal Paid
UNIVERSAL HEALTHCARE SERVICES INC. BAKERSFIELD CA $24.01M
NORTHWEST SURGERY CENTER, INC. BAKERSFIELD CA $6.53M
UNIVERSAL URGENT CARE BAKERSFIELD CA $6.31M
PAIN CLINICS OF CENTRAL CALIFORNIA, INC. BAKERSFIELD CA $5.87M
UNIVERSAL URGENT CARE AND OCCUPATIONAL MEDICINE, INC. BAKERSFIELD CA $3.77M
UNIVERSAL HEALTHCARE SERVICES, INC. BAKERSFIELD CA $2.81M
UNIVERSAL HEALTHCARE SERVICES, INC. BAKERSFIELD CA $2.19M
PREFERRED CARE MANAGEMENT INC BAKERSFIELD CA $50.86

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 17,167 $1.03M
2019 28,841 $1.46M
2020 24,967 $1.39M
2021 10,522 $662K
2022 17,290 $929K
2023 11,472 $561K
2024 3,617 $218K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 40,380 36,015 $2.98M
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 17,352 17,038 $1.63M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,696 9,704 $771K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3,731 3,718 $282K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,130 965 $209K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,196 1,143 $87K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 8,547 7,348 $58K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 5,475 5,167 $52K
J0696 Injection, ceftriaxone sodium, per 250 mg 4,060 3,024 $26K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 3,488 3,290 $25K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,420 3,138 $23K
81003 3,608 3,260 $21K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 238 238 $19K
86328 1,631 1,573 $18K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 2,436 2,230 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,898 1,853 $13K
71046 Radiologic examination, chest; 2 views 957 903 $9K
J1030 Injection, methylprednisolone acetate, 40 mg 1,051 971 $9K
81025 248 243 $2K
87428 143 140 $2K
93000 120 116 $1K
A6448 Light compression bandage, elastic, knitted/woven, width less than three inches, per yard 123 121 $985.28
69209 15 14 $652.84
87400 1,048 614 $588.96
99442 207 185 $524.56
87807 151 150 $411.85
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 70 69 $378.28
81002 203 200 $367.30
J2550 Injection, promethazine hcl, up to 50 mg 65 63 $367.03
73630 12 12 $251.15
73610 13 12 $139.78
73560 14 14 $54.78
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 49 49 $27.40
82947 22 20 $5.35
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 15 15 $0.00
H0033 Oral medication administration, direct observation 37 37 $0.00
90630 14 13 $0.00
73130 13 12 $0.00